Format

Send to

Choose Destination
See comment in PubMed Commons below
Dermatol Online J. 2012 Oct 15;18(10):15.

Caution advised in interpretation of US FDA risk classification for dermatological medications during pregnancy.

Author information

1
University of California, San Francisco, Department of Dermatology, San Francisco, California, USA.

Abstract

Prescription and non-prescription medications are frequently used by women of childbearing age. As many as 40 to 80 percent of women receive at least one prescription drug during pregnancy. It is essential to understand the potential teratogenicity of medications and offer pregnant women appropriate counseling. Available classification references include the Swedish Catalogue of Approved Drugs, the US Food and Drug Administration, the Australian system, and the Evidence-Based Medicine system.

PMID:
23122022
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center